142 related articles for article (PubMed ID: 23701077)
1. Imaging-guided radiofrequency ablation of cystic renal neoplasms.
Allen BC; Chen MY; Childs DD; Zagoria RJ
AJR Am J Roentgenol; 2013 Jun; 200(6):1365-9. PubMed ID: 23701077
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses.
Felker ER; Lee-Felker SA; Alpern L; Lu D; Raman SS
AJR Am J Roentgenol; 2013 Nov; 201(5):1029-35. PubMed ID: 24147473
[TBL] [Abstract][Full Text] [Related]
3. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
4. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of radiofrequency ablation for treatment of Bosniak IV renal cysts.
Menezes MR; Viana PC; Yamanari TR; Arap MA; Reis LO; Nahas W
Int Braz J Urol; 2016; 42(3):456-63. PubMed ID: 27286107
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
Park JJ; Park BK; Park SY; Kim CK
J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
[TBL] [Abstract][Full Text] [Related]
11. Renal function outcomes for multifocal renal neoplasms managed by radiofrequency ablation.
Gupta P; Allen BC; Chen MY; Childs DD; Kota G; Zagoria RJ
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1329-35. PubMed ID: 23361116
[TBL] [Abstract][Full Text] [Related]
12. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and complications related to the management of Bosniak cystic renal lesions.
Smith AD; Allen BC; Sanyal R; Carson JD; Zhang H; Williams JH; Collins C; Griswold M; Zhang X
AJR Am J Roentgenol; 2015 May; 204(5):W550-6. PubMed ID: 25905961
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
16. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation--incidence and clinical importance in 101 consecutive patients.
Schirmang TC; Mayo-Smith WW; Dupuy DE; Beland MD; Grand DJ
Radiology; 2009 Oct; 253(1):263-9. PubMed ID: 19703853
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
18. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
19. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery.
Castle SM; Gorbatiy V; Ekwenna O; Young E; Leveillee RJ
BJU Int; 2012 Feb; 109(3):384-7. PubMed ID: 22176671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
